These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24282819)

  • 21. Fabrication of self-assembled chitosan-dispersed LDL nanoparticles for drug delivery with a one-step green method.
    Tian J; Xu S; Deng H; Song X; Li X; Chen J; Cao F; Li B
    Int J Pharm; 2017 Jan; 517(1-2):25-34. PubMed ID: 27845214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folate-decorated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting delivery: optimization and in vivo antitumor activity.
    Zhang C; Zhang Z; Zhao L
    Drug Deliv; 2016 Jun; 23(5):1830-7. PubMed ID: 26652055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy.
    Rajkumar S; Prabaharan M
    Colloids Surf B Biointerfaces; 2018 Oct; 170():529-537. PubMed ID: 29966906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gefitinib loaded folate decorated bovine serum albumin conjugated carboxymethyl-beta-cyclodextrin nanoparticles enhance drug delivery and attenuate autophagy in folate receptor-positive cancer cells.
    Shi Y; Su C; Cui W; Li H; Liu L; Feng B; Liu M; Su R; Zhao L
    J Nanobiotechnology; 2014 Oct; 12():43. PubMed ID: 25358257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
    Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
    Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells.
    Li P; Wang Y; Zeng F; Chen L; Peng Z; Kong LX
    Carbohydr Res; 2011 May; 346(6):801-6. PubMed ID: 21397214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folate-Chitosan Nanoparticles Loaded with Ursolic Acid Confer Anti-Breast Cancer Activities in vitro and in vivo.
    Jin H; Pi J; Yang F; Jiang J; Wang X; Bai H; Shao M; Huang L; Zhu H; Yang P; Li L; Li T; Cai J; Chen ZW
    Sci Rep; 2016 Jul; 6():30782. PubMed ID: 27469490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folic acid receptor-targeted human serum albumin nanoparticle formulation of cabazitaxel for tumor therapy.
    Sun Y; Zhao Y; Teng S; Hao F; Zhang H; Meng F; Zhao X; Zheng X; Bi Y; Yao Y; Lee RJ; Teng L
    Int J Nanomedicine; 2019; 14():135-148. PubMed ID: 30613142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzylguanidine and Galactose Double-Conjugated Chitosan Nanoparticles with Reduction Responsiveness for Targeted Delivery of Doxorubicin to CXCR 4 Positive Tumors.
    Kong F; Tang C; Yin C
    Bioconjug Chem; 2020 Oct; 31(10):2446-2455. PubMed ID: 32991164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folic acid conjugated glycol chitosan micelles for targeted delivery of doxorubicin: preparation and preliminary evaluation in vitro.
    Yu J; Xie X; Wu J; Liu Y; Liu P; Xu X; Yu H; Lu L; Che X
    J Biomater Sci Polym Ed; 2013; 24(5):606-20. PubMed ID: 23565871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-responsive folic acid conjugated glycol chitosan nanoparticle for enhanced tumor targeting treatment.
    Jang EH; Shim MK; Kim GL; Kim S; Kang H; Kim JH
    Int J Pharm; 2020 Apr; 580():119237. PubMed ID: 32201251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular uptake and antitumor activity of DOX-hyd-PEG-FA nanoparticles.
    Ye WL; Du JB; Zhang BL; Na R; Song YF; Mei QB; Zhao MG; Zhou SY
    PLoS One; 2014; 9(5):e97358. PubMed ID: 24828815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folate mediated self-assembled phytosterol-alginate nanoparticles for targeted intracellular anticancer drug delivery.
    Wang J; Wang M; Zheng M; Guo Q; Wang Y; Wang H; Xie X; Huang F; Gong R
    Colloids Surf B Biointerfaces; 2015 May; 129():63-70. PubMed ID: 25829128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Receptor-mediated gene delivery by folic acid-modified stearic acid-grafted chitosan micelles.
    Du YZ; Cai LL; Li J; Zhao MD; Chen FY; Yuan H; Hu FQ
    Int J Nanomedicine; 2011; 6():1559-68. PubMed ID: 21845046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chitosan-tripolyphosphate nanoparticles functionalized with a pH-responsive amphiphile improved the in vitro antineoplastic effects of doxorubicin.
    Nogueira-Librelotto DR; Scheeren LE; Vinardell MP; Mitjans M; Rolim CMB
    Colloids Surf B Biointerfaces; 2016 Nov; 147():326-335. PubMed ID: 27543694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chitosan based copolymer-drug conjugate and its protein targeted polyelectrolyte complex nanoparticles to enhance the efficiency and specificity of low potency anticancer agent.
    Sutar YB; Telvekar VN
    Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():393-406. PubMed ID: 30184765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.
    Shen Z; Li Y; Kohama K; Oneill B; Bi J
    Pharmacol Res; 2011 Jan; 63(1):51-8. PubMed ID: 21035550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folic acid-modified soy protein nanoparticles for enhanced targeting and inhibitory.
    Cheng X; Wang X; Cao Z; Yao W; Wang J; Tang R
    Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():298-307. PubMed ID: 27987711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.